Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program

International Journal of Cancer

Volumn 130, Issue 5, 2012, Pages 1128-1135

  Gök, Murat ^a   Van Kemenade, Folkert J ^a   Heideman, Daniëlle A M ^a   Berkhof, Johannes ^a   Rozendaal, Lawrence ^a   Spruyt, Johan W M ^a   Beliën, Jeroen A M ^a   Babovic, Milena ^b   Snijders, Peter J F ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Regional Screening Organisation   (Netherlands)

Author keywords

cervical carcinoma; cervical intraepithelial neoplasia; human papillomavirus; hybrid capture 2; non attendees; population based cervical screening; self sampling

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN CELL; PAPILLOMAVIRUS INFECTION; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA; VAGINA CYTOLOGY; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PATIENT COMPLIANCE; RISK; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84155165635     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26128     Document Type: Article

References (17)

1. Rebolj M, van BM, Berkers LM, Habbema D,. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007; 120: 806-12. (Pubitemid 46175400)
2. Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van BM, Helmerhorst TJ, Meijer CJ,. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505-10. (Pubitemid 46355385)
3. Bos AB, Rebolj M, Habbema JD, van Ballegooijen M,. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006; 119: 2372-5. (Pubitemid 44546958)
4. Cuzick J,. Human papillomavirus testing for primary cervical cancer screening. JAMA 2000; 283: 108-9. (Pubitemid 30038393)
5. Wright TC, Jr, Denny L, Kuhn L, Pollack A, Lorincz A,. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81-6. (Pubitemid 30038387)
6. Kinney W, Sung HY, Kearney KA, Miller M, Sawaya G, Hiatt RA,. Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Gynecol Oncol 1998; 71: 428-30. (Pubitemid 29022332)
7. Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Belien JA, Babovic M, Snijders PJ, Meijer CJ,. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: c1040-1047.
8. Hanselaar AG,. Criteria for organized cervical screening programs. Special emphasis on The Netherlands program. Acta Cytol 2002; 46: 619-29. (Pubitemid 34787417)
9. Rijkaart DC, Berkhof J, van Kemenade FJ, Rozendaal L, Verheijen RH, Bulk S, Herreilers ME, Verweij WM, Snijders PJ, Meijer CJ,. Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (vusa-screen study). Int J Cancer 2010; 126: 2175-81.
10. Hesselink AT, Bulkmans NW, Berkhof J, Lorincz AT, Meijer CJ, Snijders PJ,. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol 2006; 44: 3680-5. (Pubitemid 46768821)
11. Bulk S, van Kemenade FJ, Rozendaal L, Meijer CJ,. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004; 57: 388-93. (Pubitemid 38446257)
12. Janerich DT, Hadjimichael O, Schwartz PE, Lowell DM, Meigs JW, Merino MJ, Flannery JT, Polednak AP,. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 1995; 85: 791-4.
13. Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, White R, FitzGerald JM,. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005; 81: 207-12. (Pubitemid 40835044)
14. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F,. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007; 105: 530-5. (Pubitemid 46590347)
15. Tamalet C, Richet H, Carcopino X, Henry M, Leretraite L, Heid P, Leandri FX, Sancho-Garnier H, Piana L,. Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France. J Med Virol 2010; 82: 1431-7.
16. Brink AA, Meijer CJ, Wiegerinck MA, Nieboer TE, Kruitwagen RF, van Kemenade F, Fransen DN, Hesselink AT, Berkhof J, Snijders PJ,. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol 2006; 44: 2518-23. (Pubitemid 44092421)
17. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ,. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516-20.